Monday, October 22, 2018
- 9:00AM-11:00AM
-
Abstract Number: 1811
Efficacy and Safety of Interferon α2a As an Add-on Treatment for Refractory Behcet’s Uveitis
Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease- 9:00AM-11:00AM
-
Abstract Number: 1791
Efficacy of Apremilast for Oral Ulcers Associated with Active Behçet’s Syndrome in a Phase III Study: A Prespecified Analysis By Baseline Patient Demographics and Disease Characteristics
Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease- 9:00AM-11:00AM
-
Abstract Number: 1745
Efficacy of Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss) Treatments According to the Type of Manifestations Based on Analysis of 376 Patients
Vasculitis – ANCA-Associated Poster I- 9:00AM-11:00AM
-
Abstract Number: 1513
Efficacy of Etanercept By Body Mass Index in Women and Men with Rheumatoid Arthritis: A Post Hoc Analysis of Three Randomized Trials
Rheumatoid Arthritis – Treatments Poster II: PROs, Safety and Comorbidity- 9:00AM-11:00AM
-
Abstract Number: 1367
Efficacy of Intra-Articular Cntx-4975 for Knee OA Pain Varies with Radiographic Presence of OA in the Opposite Knee
Osteoarthritis – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 1308
Efficacy of Rituximab for Connective Tissue Disease (CTD) Associated Interstitial Lung Disease (ILD):a Single Center Study of 47 Patients
Miscellaneous Rheumatic and Inflammatory Diseases Poster II: Interstitial Lung Disease, Still's Disease, FMF, Polychondritis- 9:00AM-11:00AM
-
Abstract Number: 1475
Eicosanoid Mediators of Systemic Inflammation and Arthritis in the Elderly
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis- 9:00AM-11:00AM
-
Abstract Number: 1255
Elevated Serum Globulin Gap As a Reliable and Cost-Savings Marker of Inflammation in Patients with Systemic Rheumatic Diseases
Measures and Measurement of Healthcare Quality Poster II- 9:00AM-11:00AM
-
Abstract Number: 1350
Elevated Serum Levels of Soluble CD146 and CD146 Autoantibody in Patients with Polymyositis/Dermatomyositis
Muscle Biology, Myositis and Myopathies Poster II: Basic and Translational Science- 9:00AM-11:00AM
-
Abstract Number: 1499
Elevated Serum MMP-3 in Remission Predicts Relapsed in Patients with Rheumatoid Arthritis
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis- 9:00AM-11:00AM
-
Abstract Number: 993
Elucidating the Role of the Lymphatic System in the Pathogenesis of Psoriasis and Psoriatic Arthritis
Cytokines and Cell Trafficking Poster- 9:00AM-11:00AM
-
Abstract Number: 1415
Emapalumab, an Anti-Interferon Gamma Monoclonal Antibody in Two Patients with NLRC4-Related Disease and Severe Hemophagocytic Lymphohistiocytosis (HLH)
Pediatric Rheumatology – Clinical Poster II: Autoinflammatory Disorders, Scleroderma, and Miscellaneous- 9:00AM-11:00AM
-
Abstract Number: 1409
Empowerment in Hispanic Rheumatoid Arthritis Patients: A Validation Study
Patient Outcomes, Preferences, and Attitudes Poster I: Patient-Reported Outcomes- 9:00AM-11:00AM
-
Abstract Number: 1094
Endogenous Ifnβ Production Is Required for Efficient BCR Crosslinking and Survival of SLE B Cells